CDT EQUITY INC. Earnings Per Share (Basic)
CDT EQUITY INC. (CDT) reported Earnings Per Share (Basic) of -$8.71 per share for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-09-08
- CDT EQUITY INC. earnings per share, basic for the quarter ending 2026-06-30 was -$8.71.
- CDT EQUITY INC. earnings per share, basic for the quarter ending 2026-03-31 was -$5.56.
- CDT EQUITY INC. earnings per share, basic for the quarter ending 2025-09-30 was -$13.16.
- CDT EQUITY INC. earnings per share, basic for the quarter ending 2025-06-30 was -$10940.11.
- CDT EQUITY INC. earnings per share, basic for fiscal 2023 was -$0.79.
- CDT EQUITY INC. earnings per share, basic for fiscal 2022 was -$0.13.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$8.71 S-1 · filed 2026-09-08 | -$28.60 S-1 · filed 2026-09-08 | ||||||
| 2026-03-31 | -$5.56 10-Q · filed 2026-07-15 | |||||||
| 2025-12-31 | -$11779.12 S-1 · filed 2026-09-08 | -$1177.89 10-K · filed 2026-04-15 | ||||||
| 2025-09-30 | -$13.16 10-Q · filed 2025-11-13 | -$74.92 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$10940.11 S-1 · filed 2026-09-08 | -$5.46 10-Q · filed 2025-08-14 | -$31557.04 S-1 · filed 2026-09-08 | -$15.77 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | -$3670.27 10-Q · filed 2026-07-15 | -$1.32 10-Q · filed 2025-05-15 | ||||||
| 2024-12-31 | $123.63 derived: net income ÷ weighted average shares · filed 2026-09-08 | $1453.73 derived: net income ÷ weighted average shares · filed 2026-09-08 | -$1154.31 derived: net income ÷ weighted average shares · filed 2026-09-08 | -$612360.21 S-1 · filed 2026-09-08 | -$20.53 10-K · filed 2025-03-28 | |||
| 2024-09-30 | -$889.58 10-Q · filed 2025-11-13 | -$0.07 10-Q · filed 2024-11-14 | -$419.28 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$2359.18 10-Q · filed 2025-11-13 | -$0.20 10-Q · filed 2024-11-14 | $0.32 derived: net income ÷ weighted average shares · filed 2025-11-13 | ||
| 2024-06-30 | -$109.33 10-Q · filed 2025-08-14 | -$0.07 10-Q · filed 2024-08-12 | -$181.51 10-Q · filed 2025-08-14 | -$0.12 10-Q · filed 2024-08-12 | $0.14 derived: net income ÷ weighted average shares · filed 2025-08-14 | $0.19 derived: net income ÷ weighted average shares · filed 2025-08-14 | ||
| 2024-03-31 | -$4.81 10-Q/A · filed 2025-08-14 | -$0.05 10-Q · filed 2024-05-14 | $0.03 derived: net income ÷ weighted average shares · filed 2025-08-14 | $0.02 derived: net income ÷ weighted average shares · filed 2025-08-14 | $0.16 derived: net income ÷ weighted average shares · filed 2025-08-14 | |||
| 2023-12-31 | -$0.00 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.06 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.79 10-K · filed 2025-03-28 | -$0.01 10-K · filed 2024-04-16 | |||
| 2023-09-30 | $0.04 10-Q · filed 2024-11-14 | $0.03 10-Q · filed 2023-11-20 | $0.01 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.01 10-Q · filed 2024-11-14 | -$0.04 10-Q · filed 2023-11-20 | -$0.06 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-06-30 | -$0.03 10-Q/A · filed 2024-11-14 | -$1053.00 10-K · filed 2024-04-16 | -$0.05 10-Q/A · filed 2024-11-14 | -$1889.00 10-K · filed 2024-04-16 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||
| 2023-03-31 | -$0.03 10-Q/A · filed 2024-11-14 | -$835.00 10-K · filed 2024-04-16 | -$0.08 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$0.11 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2022-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$0.09 derived: net income ÷ weighted average shares · filed 2024-04-16 | -$0.13 10-K · filed 2024-04-16 | |||||
| 2022-09-30 | -$0.03 10-Q/A · filed 2023-11-21 | -$0.06 10-Q/A · filed 2023-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |